Epidemiology and Clinical Features of Heart Failure with Preserved Ejection Fraction

被引:38
作者
Teramoto, Kanako [1 ]
Teng, Tiew-Hwa Katherine [1 ,2 ,3 ]
Chandramouli, Chanchal [1 ,3 ]
Tromp, Jasper [1 ,3 ,4 ,5 ]
Sakata, Yasuhiko [6 ]
Lam, Carolyn S. P. [1 ,3 ,7 ,8 ]
机构
[1] Natl Heart Ctr, Singapore, Singapore
[2] Univ Western Australia, Sch Allied Hlth, Perth, Australia
[3] Duke Natl Univ Singapore, Med Sch, Singapore, Singapore
[4] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore
[5] Natl Univ Hlth Syst, Singapore, Singapore
[6] Natl Cerebral & Cardiovasc Ctr, Osaka, Japan
[7] Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands
[8] Natl Heart Ctr Singapore, 5 Hosp Dr, Singapore 169609, Singapore
基金
英国医学研究理事会;
关键词
Heart failure with preserved ejection fraction; epidemiology; risk factors; comorbidities; cluster analysis; sex differences; prognosis; VENTRICULAR SYSTOLIC FUNCTION; QUALITY-OF-LIFE; ATRIAL-FIBRILLATION; SEX-DIFFERENCES; OUTCOMES; PREVALENCE; COMMUNITY; MORTALITY; CLASSIFICATION; DYSFUNCTION;
D O I
10.15420/cfr.2022.06
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Heart failure (HF) with preserved ejection (HFpEF) constitutes a large and growing proportion of patients with HF around the world, and is now responsible for more than half of all HF cases in ageing societies. While classically described as a condition of elderly, hypertensive women, recent studies suggest heterogeneity in clinical phenotypes involving differential characteristics and pathophysiological mechanisms. Despite a paucity of disease-modifying therapy for HFpEF, an understanding of phenotypic similarities and differences among patients with HFpEF around the world provides the foundation to recognise the clinical condition for early treatment, as well as to identify modifiable risk factors for preventive intervention. This review summarises the epidemiology of HFpEF, its common clinical features and risk factors, as well as differences by age, comorbidities, race/ethnicity and geography.
引用
收藏
页数:8
相关论文
共 85 条
[1]   Cardiorenal syndrome in heart failure with preserved ejection fractionan under-recognized clinical entity [J].
Agrawal, Akanksha ;
Naranjo, Mario ;
Kanjanahattakij, Napatt ;
Rangaswami, Janani ;
Gupta, Shuchita .
HEART FAILURE REVIEWS, 2019, 24 (04) :421-437
[2]   Association Between Use of Statins and Mortality in Patients With Heart Failure and Ejection Fraction of ≥50% [J].
Alehagen, Urban ;
Benson, Lina ;
Edner, Magnus ;
Dahlstrom, Ulf ;
Lund, Lars H. .
CIRCULATION-HEART FAILURE, 2015, 8 (05) :862-870
[3]   Empagliflozin in Heart Failure with a Preserved Ejection Fraction [J].
Anker, Stefan D. ;
Butler, Javed ;
Filippatos, Gerasimos ;
Ferreira, Joao P. ;
Bocchi, Edimar ;
Boehm, Michael ;
Brunner-La Rocca, Hans-Peter ;
Choi, Dong-Ju ;
Chopra, Vijay ;
Chuquiure-Valenzuela, Eduardo ;
Giannetti, Nadia ;
Gomez-Mesa, Juan Esteban ;
Janssens, Stefan ;
Januzzi, James L. ;
Gonzalez-Juanatey, Jose R. ;
Merkely, Bela ;
Nicholls, Stephen J. ;
Perrone, Sergio V. ;
Pina, Ileana L. ;
Ponikowski, Piotr ;
Senni, Michele ;
Sim, David ;
Spinar, Jindrich ;
Squire, Iain ;
Taddei, Stefano ;
Tsutsui, Hiroyuki ;
Verma, Subodh ;
Vinereanu, Dragos ;
Zhang, Jian ;
Carson, Peter ;
Lam, Carolyn Su Ping ;
Marx, Nikolaus ;
Zeller, Cordula ;
Sattar, Naveed ;
Jamal, Waheed ;
Schnaidt, Sven ;
Schnee, Janet M. ;
Brueckmann, Martina ;
Pocock, Stuart J. ;
Zannad, Faiez ;
Packer, Milton .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (16) :1451-1461
[4]   Ethnic-Specific Normative Reference Values for Echocardiographic LA and LV Size, LV Mass, and Systolic Function The EchoNoRMAL Study [J].
Aune, E. ;
Brown, A. ;
Badano, L. P. ;
Cameron, V. ;
Chadha, D. S. ;
Chahal, N. ;
Chien, K. L. ;
Daimon, M. ;
Dalen, H. ;
Detrano, R. ;
Duzenli, M. Akif ;
Ezekowitz, J. ;
de Simone, G. ;
Di Pasquale, P. ;
Fukuda, S. ;
Gill, P. S. ;
Grossman, E. ;
Hobbs, F. D. R. ;
Kim, H. -K. ;
Kuznetsova, T. ;
Leung, N. K. W. ;
Linhart, A. ;
McDonagh, T. A. ;
McGrady, M. ;
McMurray, J. J. V. ;
Mill, J. G. ;
Mogelvang, R. ;
Muiesan, M. L. ;
Ng, A. C. T. ;
Ojji, D. ;
Otterstad, J. E. ;
Petrovic, D. J. ;
Poppe, K. K. ;
Prendergast, B. ;
Rietzschel, E. ;
Schirmer, H. ;
Schvartzman, P. ;
Senior, R. ;
Simova, I. ;
Sliwa, K. ;
Stewart, S. ;
Squire, I. B. ;
Takeuchi, M. ;
Thomas, L. ;
Whalley, G. A. ;
Altman, D. G. ;
Perera, R. ;
Poppe, K. K. ;
Triggs, C. M. ;
Yeung, H. Au .
JACC-CARDIOVASCULAR IMAGING, 2015, 8 (06) :656-665
[5]   Anti-rheumatic drug use and risk of hospitalization for congestive heart failure in rheumatoid arthritis [J].
Bernatsky, S ;
Hudson, M ;
Suissa, S .
RHEUMATOLOGY, 2005, 44 (05) :677-680
[6]   Outcome of heart failure with preserved ejection fraction in a population-based study [J].
Bhatia, R. Sacha ;
Tu, Jack V. ;
Lee, Douglas S. ;
Austin, Peter C. ;
Fang, Jiming ;
Haouzi, Annick ;
Gong, Yanyan ;
Liu, Peter P. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (03) :260-269
[7]   Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure [J].
Bozkurt, Biykem ;
Coats, Andrew J. S. ;
Tsutsui, Hiroyuki ;
Abdelhamid, Ca Magdy ;
Adamopoulos, Stamatis ;
Albert, Nancy ;
Anker, Stefan D. ;
Atherton, John ;
Boehm, Michael ;
Butler, Javed ;
Drazner, Mark H. ;
Felker, G. Michael ;
Filippatos, Gerasimos ;
Fiuzat, Mona ;
Fonarow, Gregg C. ;
Gomez-Mesa, Juan-Esteban ;
Heidenreich, Paul ;
Imamura, Teruhiko ;
Jankowska, Ewa A. ;
Januzzi, James ;
Khazanie, Prateeti ;
Kinugawa, Koichiro ;
Lam, Carolyn S. P. ;
Matsue, Yuya ;
Metra, Marco ;
Ohtani, Tomohito ;
Piepoli, Massimo Francesco ;
Ponikowski, Piotr ;
Rosano, Giuseppe M. C. ;
Sakata, Yasushi ;
Starling, Randall C. ;
Teerlink, John R. ;
Vardeny, Orly ;
Yamamoto, Kazuhiro ;
Yancy, Clyde ;
Zhang, Jian ;
Zieroth, Shelley .
EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 (03) :352-380
[8]   Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND [J].
Brouwers, Frank P. ;
de Boer, Rudolf A. ;
van der Harst, Pim ;
Voors, Adriaan A. ;
Gansevoort, Ron T. ;
Bakker, Stephan J. ;
Hillege, Hans L. ;
van Veldhuisen, Dirk J. ;
van Gilst, Wiek H. .
EUROPEAN HEART JOURNAL, 2013, 34 (19) :1424-1431
[9]   Systolic and diastolic heart failure in the community [J].
Bursi, Francesca ;
Weston, Susan A. ;
Redfield, Margaret M. ;
Jacobsen, Steven J. ;
Pakhomov, Serguei ;
Nkomo, Vuyisile T. ;
Meverden, Ryan A. ;
Roger, Veronique L. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (18) :2209-2216
[10]   Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction The PARAGON-HF Trial [J].
Chandra, Alvin ;
Vaduganathan, Muthiah ;
Lewis, Eldrin F. ;
Claggett, Brian L. ;
Rizkala, Adel R. ;
Wang, Wenyan ;
Lefkowitz, Martin P. ;
Shi, Victor C. ;
Anand, Inder S. ;
Ge, Junbo ;
Lam, Carolyn S. P. ;
Maggioni, Aldo P. ;
Martinez, Felipe ;
Packer, Milton ;
Pfeffer, Marc A. ;
Pieske, Burkert ;
Redfield, Margaret M. ;
Rouleau, Jean L. ;
van Veldhuisen, Dirk J. ;
Zannad, Faiez ;
Zile, Michael R. ;
McMurray, John J. V. ;
Solomon, Scott D. .
JACC-HEART FAILURE, 2019, 7 (10) :862-874